medigraphic.com
Órgano Ofical de la Facultad de Estomatología de la Benemérita Universidad Autónoma de Puebla

2018, Number 61

<< Back Next >>

Oral 2018; 19 (61)

Oral disorders secondary to chemo and radiotherapy in patients with head and neck cancer

Vega-Menchaca N, Corral-Apodaca MM, Estrada-Esquivel B, Nevárez-Rascón A

Language: Spanish
References: 64
Page: 1644-1651
PDF size: 228.74 Kb.


ABSTRACT

Cancer is the second leading cause of death in the world, end the third cause of death in Mexico. Head and neck cancer is the tenth cause of death worldwide. The main treatments for this pathology are resection, radiotherapy and chemotherapy, alone or combined. Radiation therapy and chemotherapy seek to attack cancer cells, although they can affect normal cells near the irradiated area or tissues of rapid cell renewal, in phases of cell cycle equal to that of tumor cells. As a consequence of the condition of normal cells there is the possibility of presenting pathologies secondary to these treatments. The aim of this review of the literature is to describe oral disorders secondary to chemo and radiotherapy in patients with head and neck cancer.


REFERENCES

  1. Cáncer. Temas de Salud. OMS 2018. Disponible en: http://www. who.int/es/news-room/fact-sheets/detail/the-top-10-causes-ofdeath

  2. Fitzmaurice, C., Allen, C., Barber, R. M., Barregard, L., Bhutta, Z. A., Brenner, H., & Fleming, T. (2017). Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA oncology, 3(4), 524-548

  3. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Disponible en: http://globocan.iarc.fr

  4. Mehanna H, Paleri V, West C M L, Nutting C. Cáncer de cabeza y cuello. Revisión de las presentaciones frecuentes, estudios comunes y nuevas técnicas de diagnóstico. Detección y prevención. BMJ 2010; 341:c4684

  5. López Martín A, Ballesteros A, Cáncer de cabeza y cuello. Sociedad Española de Oncología Médica (SEOM) 2013. Disponible en: https://seom.org/info-sobre-el-cancer/orl

  6. Esco R., Valencia J., Polo S.. Radioterapia y citoprotección: Estado actual. Oncología (Barc.) 2004 Jul 27(7): 40-46.

  7. http://www.cancer.org/acs/groups/cid/documents/ webcontent/002996-pdf

  8. Álvarenanz GGJ, López CRV, Botero TJE, Botero GSM, Cardona ÁDP, Carmona RPA, Hernández AJE. Alteraciones en la cavidad bucal en pacientes tratados con radioterapia de cabeza y cuello. Medellín, Colombia Rev Odont Mex 2017; 21 (2)

  9. Infante-Cossío P, Gutiérrez-Pérez JL, Bullón-Fernández P. Complicaciones de la radioterapia y la quimioterapia en pacientes con cáncer en la cavidad bucal. Medicina bucal práctica. Santiago de Compostela: Danú; 2000. p. 646-57

  10. Oral Complications of Chemotherapy and Head/Neck Radiation: National Cancer Institute. 2008. ov/cancertopics /pdq / supportivecare/oralcomplications/HealthProfessional.

  11. Organización Mundial de la Salud. Ginebra: 2002. (Actualizada en 2008) Acceso Online: http://www.who.int/infobase/report. aspx?iso= MEX&rid

  12. Aldaco-Sarvide, F., Pérez-Pérez, P., Cervantes-Sánchez, G., Torrecillas-Torres, L., Erazo-Valle-Solís, A. A., Cabrera- Galeana, P.,& Cárdenas-Cárdenas, E. (2018). Mortalidad por cáncer en México: actualización 2015. cáncer, 85, 1.

  13. Mehanna H, Paleri V, West C M L, Nutting C. Cáncer de cabeza y cuello. Revisión de las presentaciones frecuentes, estudios comunes y nuevas técnicas de diagnóstico. Detección y prevención. BMJ 2010;341:c4684

  14. Mathers CD, Loncar D (2006) Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med 2008 3(11): e442

  15. http://cancercabezaycuello.org/cabeza-y-cuello.php

  16. Redondo, D. C. H., & Montoya, J. H. E. (2012). Complicaciones orales en pacientes sometidos a radioterapia: revisión de literatura. Universitas Odontológica, 31(67), 10.

  17. Instituto Nacional de Cáncer – INCA, 1996-2002. Disponible en: www.inca.org.br

  18. American College of Radiology and the Radiological Society of North America. Brain Tumors. Accessed at www.radiologyinfo. org/en/info.cfm?pg=thera-brain&bhcp=1 onAugust 29, 2011.

  19. Hancock P, Epstein B, Robins Sadler G, Oral and dental management related to radiation therapy for head and neck cancer.J Can Dent Assoc 2003; 69(9):585-90.

  20. Vissink, J. Jansma, F.K.L. Spijkervet, F.R. Burlage and R.P. Coppes. Oral Sequelae of Head and Neck Radiotherapy. Crit Rev Oral Biol Med 2003. 14(3): 199-212.

  21. Hong C, Napeñas J, Hodgson B, stockman M, Mathers-Stauffer V, Elting L, . Spijkervet F, Brennan M. A systematic review of dental disease in patients undergoing cancer therapy. Multinational Association of Supportive Care in Cancer (MASCC)/ International Society of Oral Oncology (ISOO). Support Care Cancer 2010, 18:1007-1021

  22. Nicolatau-Galitis, et al. Oral Mucositis, Pain and Xerostomia in 135 Head and Neck Cancer Patients Receiving Radiotherapy with or without Chemotherapy. The Open Cancer Journal, 2011, Vol 4, 7-17

  23. Caribé-Gomes F, Chimenos-Küstner E, López-López J, Finestres- Zubeldia F, Guix-Melcior B. Manejo odontológico de las complicaciones de la radioterapia y quimioterapia en el cáncer oral. Med Oral 2003;8:178-87.

  24. De Vega-Massana M, Guedea-Edo F, Craven-Bartle J. Estado actual de la radioterapia en el cáncer de cabeza y cuello. Rev Cancer 1997;4:141-8.

  25. Herrera Herrera A., Díaz Caballero A., Herrera Barrios F., Fang Mercado L.C.. Osteorradionecrosis como secuela de la radioterapia. Odontoestomatol. 2012. 28 (4):175-180

  26. Cedeño M, Rivas R N, Tuliano C. Manifestaciones bucales de los pacientes sometidos a radioterapia en cabeza y cuello, pautas de atención odontológica. Acta Odontol Venezol 2014. 52 (1).

  27. Jham B, Reis P, Miranda E, Lopes R, carvalho a, Scheper M, Freire a. Oral health status of 207 head and neck cancer patients before, during and after radiotherapy. Clinical Oral Investigations. March 2008, Volume 12, Issue 1, pp 19-24

  28. Gupta T, Kannan S, Ghosh-Laskar S, Agarwal JP. Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma. PLoS ONE [Internet]. 2018 Jul 6 [cited 2018 Nov 10];1–15. Available from: http://www.proxydgb.buap. mx:2048/login?url=http://search.ebscohost.com/login.aspx?direct= true&db=a9h&AN=130568136&lang=es&site=eds-live

  29. Manterola A., Romero P., Asín G., Rico M., Sola A., Vila M.T.. Aplicación clínica de la radioterapia de intensidad modulada. Anales Sis San Navarra [Internet]. 2009 [citado 2018 Nov 11] ; 32( Suppl 2 ): 21-31. Disponible en: http://scielo.isciii.es/scielo. php?script=sci_arttext&pid=S1137-66272009000400003&lng=es.

  30. Deng J-Y, Wang C, Shi X-H, Jiang G-L, Wang Y, Liu Y, et al. Reduced toxicity with three-dimensional conformal radiotherapy or intensity-modulated radiotherapy compared with conventional two-dimensional radiotherapy for esophageal squamous cell carcinoma: a secondary analysis of data from four prospective clinical trials. Diseases of the Esophagus [Internet]. 2017 Jul [cited 2018 Nov 10];30(7):1–7. Available from: http://www.proxydgb. buap.mx:2048/login?url=http://search.ebscohost.com/login.aspx? direct=true&db=a9h&AN=123767926&lang=es&site=eds-live

  31. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW & Goodman Gilman A. Goodman & Gilman. Las bases farmacológicas de la terapéutica. Ed. Interamericana McGraw Hill. Madrid, 1996.

  32. Fuenmayor, J, Gamez Hoyos, R, Montaño, RF. Anticuerpos Monoclonales en el Tratamiento del Cáncer. Terapia dirigida para Tumores Sólidos. Rev Venez Oncol. 2013; 25(4): 236-54.

  33. Lalla RV, Saunders DP, Peterson DE, et al. Chemotherapy or Radiation Induced Oral Mucositis. Dent Clin N Am 2014.58:341-349.

  34. De Sanctis V, Bossi P, Sanguineti G, Trippa F, Ferrai D, et al. Mucositis in head and neck cancer patients treated with radiotherapy and systematic therapies: review and consensus statements. Clinical reviews in Oncology/Hematology 2016.100:147-166.

  35. Sonis ST. The pathobiology of mucositis. Nat Rev Cáncer 2004; 4: 277-84

  36. Spindola Antunes, H., da Silva Santos, P. S., Coracin, F. L., Silva, L., Badauy, G., de Souza, L. A., Alberto, L. (2014). ORAL MUCOSITIS: PREVENTION AND TREATMENT. International Journal of Clinical Dentistry, 7(1).

  37. Ruiz-Esquide G. Nervi B. Vargas A. Maiz A. Tratamiento y prevención de la mucositis oral asociada al tratamiento del cáncer. Rev. Méd. Chile 2011, vol.139, n.3, pp. 373-381. ISSN 0034-9887

  38. Turner M D, Hyposalivation and xerostomia: Etiology, complications, and medical management. Dental Clincs of North America 2016. 60:435-443.

  39. Rodríguez Pulido, J. I., Martínez Sandoval, G., Rodríguez Franco, N. I., Chapa Arizpe, M. G., & Solís Soto, J. M. (2017). Terapia farmacológica y avances terapéuticos en xerostomía e hiposalivación. Revista de la Asociación Dental Mexicana, 74(5), 221-223.

  40. Lin CY, JU S, Chia J, Chang C, Chang CW, Chen MH. Effects of radiotherapy on salivary gland function in patients with head and neck cancers. Journal of Dental Sciences 2015. 10:25-262.

  41. González-Medina MA., Malpica-Sánchez E, Macías-Jiménez B., Xerostomia. Gaceta Mex de Oncología. 2013. Vol 12 Num 2

  42. Caudell JJ, Schaner PE, Meredith RF, Locher JL, Nabell LM, Carroll WR, et al. Factors associated with long term dysphagia after definitive radiotherapy for locally advanced head and neck cancer. Int J Radiat Oncol 2009; 73:410-5.

  43. Russi EG, Corvo R, Merlotti A, alterio D, Franco P, Pergolizzi S, et al. Swallowing dysfunction in head and neckcancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. Cancer Treat Rev 2012; 38:1033-49.

  44. Denaro N, Merlano MC, Russi EG. Dysphagia in head and neck cancer patients: pretreatment evaluation, predictive factors, and assessment during radio-chemotherapy, recommendations. Clin Exp Otorhinolaryngol 2013;117-26.

  45. Shindler A, Denaro N, Russi EG, Pizzorni N, Bossi P, Merloti A, et al. Dysphagia in head and neck cancer patients trated with radiotherapy and systematic therapies: Literature review and consensus. Critical Reviews in Oncology/Hematology 2015.96:372-384.

  46. Vissink, F.R. Burlage, F.K.L. Spijkervet, J. Jansma and R.P. Coppes. Prevention and Treatment of the Consequences of Head and Neck Radiotherapy. Crit Rev Oral Biol Med 2003. 14(3):213-225

  47. Buzati M, nunes de Souza, Massaioshi T, Lima de Castro, Gaetti-Jardim. Influence of preventive dental treatment on mutans streptococci counts in patients undergoing head and neck radiotherapy. J Appl Oral Sci 2009; 17 (sp. issue)5-12.

  48. Deng J, Jackson L, Eptein JB, Migliorati CA. Dental demineralization and caries in patients with head and neck cancer. Oral Oncol 2015;51:824-31.

  49. Madrid C, de Pauli Paglioni, M, Line SR, Vasconcelos KG, Brandão, TB, Lopes MA, et al. Structural Analysis of Enamel in Teeth from Head-and-Neck Cancer Patients Who Underwent Radiotherapy. Caries research 2017, 51(2):119-128.

  50. Da Cunha S, Fonseca FP, Ramos PA, Haddad, C, Fregnani ER, Aranha A. Effects of different radiation doses on the microhardness, superficial morphology, and mineral components of human enamel. Archives of Oral Biology 2017.80:130-135.

  51. Gupta, N., Pal, M., Rawat, S., Grewal, M. S., Garg, H., Chauhan, D., Mayank, M. Radiation-induced dental caries, prevention and treatment-A systematic review. National journal of maxillofacial surgery 2015, 6(2), 160.

  52. Lalla RV, Latortue MC, Hong CH, et al.: A systematic review of oral fungal infections in patients receiving cancer therapy. Support Care Cancer 18 (8): 985-92, 2010

  53. Squier CA, Kremer MJ: Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr (29): 7-15, 2001

  54. Böhme A, Karthaus M, Hoelzer D: Antifungal prophylaxis in neutropenic patients with hematologic malignancies. Antibiot Chemother 2000. 50: 69-78.

  55. Elad S, Zadik Y, Hewson I, et al.: A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea. Support Care Cancer 18 (8): 993-1006, 2010.

  56. Elad S, Ranna V, Ariyawardana A, Correa M, Tilly V, Nair R, et al. A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions. Supportive Care in Cancer [Internet]. 2017 Feb [cited 2018 Nov 12];25(2):687. Available from: http://www.proxydgb.buap. mx:2048/login?url=http://search.ebscohost.com/login.aspx?direct= true&db=edb&AN=120437002&lang=es&site=eds-live

  57. Raber-Durlacher JE, Epstein JB, Raber J, et al.: Periodontal infection in cancer patients treated with high-dose chemotherapy. Support Care Cancer 10 (6): 466-73, 2002.

  58. Peterson DE: Pretreatment strategies for infection prevention in chemotherapy patients. NCI Monogr (9): 61-71, 1990.

  59. Güll FD, Kesting M, Schwarzer C, Deppe H. Periodontal disease- like bone loss after adjuvant radiotherapy in the head and neck region: A case report and review of the literature. Quintessence International [Internet]. 2017 Jun [cited 2018 Nov 12];48(6):451–7. Available from: http://www.proxydgb. buap.mx:2048/login?url=http%3a%2f%2fsearch.ebscohost. com%2flogin.aspx%3fdirect%3dtrue%26db%3dddh%26AN%- 3d123077282%26lang%3des%26site%3dehost-live

  60. 60 Bueno AC, Ferreira RC, Cota LO, Silva GC, Magalhães CS, Moreira AN. Comparison of different criteria for periodontitis case definition in head and neck cancer individuals. Support Care Cancer. 2015; 23 (9): 2599-2604.

  61. Chronopoulos A, Zarra T, Troltzsch M, Mahaini S, Ehrenfeld M, Otto S. Osteoradionecrosis of the mandible: a ten year single center retrospective study. Journal of Cranio-Maxilo-Facial Surgery 2015. 43:837-846.

  62. Kuhnt T, Stang A, Wienke A, VordermarkD, Schweyen R, Hey J. Potential risk factors for jaw osteoradionecrosis after radiotherapy for head and neck cancer. Radiation Oncology 2016.11:101.

  63. Rice N, Polyzois I, ekanayake K, Omer O, Stassen L. The management of osteoradionecrosis of the jaws-A review. The surgeon. 2015.13:101-109.

  64. Fan H, Kim SM, Cho YJ, Eo MY, Lee SK, Woo KM. New approach for the treatment of osteoradionecrosis with pentoxifylline and tocopherol. Biomaterials Research. 2014; 18:13.




2020     |     www.medigraphic.com